CORT Latest Headlines

Corcept rallies as EU panel backs relacorilant for platinum-resistant ovarian cancer, with EC decision eyed in Q4 2026

Market Chameleon (Mon, 21-Sep 11:39 AM)

Corcept gains EU regulatory momentum as CHMP backs relacorilant combo for platinum-resistant ovarian cancer

Market Chameleon (Fri, 18-Sep 10:27 AM)

3 things to look out for on Monday

at seekingalpha.com (Fri, 18-Sep 4:20 PM)

Catalyst Watch: Trump-Xi in DC, Meta Connect, and McDonald's Investor Day

at seekingalpha.com (Fri, 18-Sep 3:10 PM)

Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Xenon (XENE)

at www.tipranks.com (Fri, 18-Sep 12:30 PM)

Merck, Astra, Roche and Corcept among winners of EU drug recommendations this week

at seekingalpha.com (Fri, 18-Sep 9:50 AM)

10 large and mega-cap U.S. healthcare stocks with the strongest momentum grades

at seekingalpha.com (Thu, 17-Sep 10:00 AM)

Corcept Therapeutics Ups 2026 Revenue Guidance as Lifyorli Launch Accelerates Growth

Market Chameleon (Thu, 30-Jul 11:13 AM)

Corcept Therapeutics Lifts 2026 Revenue Guidance on Strong Product Launches and Expanding Clinical Pipeline

Market Chameleon (Thu, 30-Jul 7:06 AM)